RSS

CWRN Cotton & Western Mining Inc.

Last Post: 01/04/25
Followers: 42
Posts Today: 0
Views Today: 1051

CWRN Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Oct 21, 4:00 PM
Last0.0000
$ Chg0.0000
Open—
High—
Beta—
Year High0.000
Market Cap—
P/B Ratio—
EPS—
Avg Vol (30d)0
Volume—
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00010
Year Low0.000
Total Shares2.31B
Shares Out4.36B
Float2.31B
Exchange
Materials Steel

CWRN Stock Message Board Discussion

Top 10 Most Recent News Articles

GomSpace Expands Sales Leadership Across Regions

Updated Category News Views 26

GomSpace Tightens Its Sales Strategy with New Hires GomSpace, a player in the satellite and nanosatellite markets, just turned its strategy dial with the appointment of two seasoned sales veterans. They're not messing around with positioning themselves as a global contender. By pulling in Anand Iqbal Gulati as Vice President Sales for APAC and Benjamin Hamel for EMEA,...

Continue Reading
WellNet Embraces Voice AI for Provider Calls

Updated Category News Views 25

Ever met a TPA grappling over their provider call costs like a crusty sailor with a rusted anchor? Welcome to WellNet Healthcare, folks. They've tapped EHVAhealth's conversational voice AI to take a solid swing at automating those burdensome provider calls. They're no stranger to the chaos of managing member eligibility and benefits verification, and this move might just...

Continue Reading
Verismo's SynKIR-110: Revolutionizing CAR T Therapy?

Updated Category News Views 73

Clinical Stage Wonders and Bold Claims Here's the lowdown on the latest tale from Verismo Therapeutics, a name that's trying real hard to distinguish itself in the CAR T therapy arena. Grab a coffee, pal, and let's wade through what's cooking at their camp with the SynKIR™-110. Breaking Down the Science Jargon For you folks not knee-deep in immunotherapy, let me spell...

Continue Reading
Havertys Q3 Upswing Amid Tariffs and Tight Margins

Updated Category News Views 70

Havertys Delivers a Steady Third Quarter Amid Challenges Alright investors, Havertys Furniture (NYSE:HVT) just rolled out its Q3 numbers for 2026 and folks, it looks like this furniture staple is holding its ground pretty well against a backdrop rife with economic headwinds. Quarterly Numbers: A Mix of Hope and Hurdles If you’re keeping score, diluted EPS stepped up...

Continue Reading
BAC Faces Class Action as Compliance Issues Loom

Updated Category News Views 80

The air around Bank of America (NYSE: BAC) has turned a shade darker, and if you've been following the script, this was only a matter of time. With Capitol Hill heavies like Senator Elizabeth Warren banging the drum, the squabble over compliance isn't just noise—it's a full-blown siren wailing in the middle of the trading floor. Enforcement and Reaction: A Boiling Pot...

Continue Reading
Guidebook for Grounded Masculinity: A Fresh Insight

Updated Category News Views 90

New Chapter in Masculinity: Navigating the Maze Leslie Grace Eggenberger's new workbook, Becoming a Man, wades right into the tangled mess of modern masculinity, sidestepping the usual lip service about toxic behaviors. Instead, it's offering an honest-to-goodness roadmap for grounded manhood, framed around five pivotal principles: Presence, Purpose, Proactivity,...

Continue Reading
SHOPLINE's Pitch Day: 14 Brands in the Spotlight

Updated Category News Views 10

SHOPLINE's Los Angeles Event Highlights Emerging Brands Flip the calendar back to October 1, and you'll find me soaking in the scene at the sprawling halls of SHOPLINE and Plug and Play’s latest event. This wasn’t your run-of-the-mill networking affair; it was a caffeine-fueled, adrenaline-pumping showcase of 14 up-and-coming consumer brands. Now, if there's one thing...

Continue Reading
Bright Minds Faces Legal Scrutiny Over FDA Trial Hold

Updated Category News Views 85

Bright Minds Biosciences Under the Microscope Well, it looks like Bright Minds Biosciences has found itself in some hot water with investors. After the FDA put a partial hold on their Phase 2 trial for BMB-101, designed for epilepsy treatment, the stock took a nosedive. If you're holding a piece of NASDAQ:DRUG, or even if you cut your losses and ran, it's time to tune in....

Continue Reading
SK Bio Pushes FDA Approval for Cenobamate in Seizures

Updated Category News Views 22

Taking New Strides in Epilepsy Treatment Today, we’ve got SK Biopharmaceuticals banging on the FDA’s door with a pile of paperwork. They’re pushing for the green light on cenobamate to tackle primary generalized tonic-clonic (PGTC) seizures, plus expand its use to pediatric patients with the focal-onset seizure condition. Now, if you think it sounds like a big...

Continue Reading
ACLM and eClinicalWorks Expand Lifestyle Medicine Reach

Updated Category News Views 92

Changing the Game with Lifestyle Medicine When it comes to healthcare, you're always going to have the skeptics grousing about the old ways. But what happens when you take an old idea and turbocharge it with modern tech? That's where the American College of Lifestyle Medicine (ACLM) and eClinicalWorks step in. They’re throwing a new wrench into the electronic health...

Continue Reading

Top 5 Most Recently Viewed Articles

Peloton Interactive's Strategic Shift Strengthens Investment Outlook

Updated Category News Views 47

Peloton Interactive's Stock Target Improved by BMO Capital Markets Recently, BMO Capital Markets revised its outlook on Peloton Interactive (NASDAQ: PTON), raising the price target from $6.50 to $8.50. The firm retained a Market Perform rating, reflecting Peloton's strategic pivot towards enhancing profitability, which analysts have seen as a promising direction....

Continue Reading
Discover How Preply Helps Learners Achieve Language Mastery

Updated Category News Views 423

Understanding Preply's Impact on Language Learning Preply has caught the attention of the education world with its innovative approach to language learning. A recent study conducted in partnership with Leanlab Education has revealed transformative results for adult learners engaging in Preply's one-on-one personalized learning model. This research emphasizes how tailored...

Continue Reading
BlackRock Inc. Notifies Syensqo on Shareholding Changes

Updated Category News Views 256

Notification of Shareholding Changes by BlackRock Inc. BlackRock Inc. has made a significant announcement recently regarding its stake in Syensqo. This notification, aligning with Belgian transparency laws, reveals that BlackRock has crossed the 3% ownership threshold, a notable event for both investors and the market. Here is an overview of the key details surrounding...

Continue Reading
Ajna Capital Invests in Hivemapper's Innovative Mapping Network

Updated Category News Views 248

Ajna Capital Invests in the Future of Mapping Technology Ajna Capital, a prominent early-stage Web3 venture fund, has recently made headlines with a significant investment in Hivemapper, the world's pioneering decentralized mapping network. This strategic move marks a step towards reshaping how maps are created and maintained globally. The Revolutionary Concept Behind...

Continue Reading
Revolutionizing Data Management with Hitachi EverFlex Service

Updated Category News Views 201

Unlocking Potential with Hitachi EverFlex AI Data Hub as a Service In the rapidly evolving landscape of artificial intelligence (AI) and data management, organizations face significant challenges in integrating and preparing vast amounts of data. Hitachi Vantara has addressed these challenges with the introduction of their EverFlex AI Data Hub as a Service, a pioneering...

Continue Reading